جست‌وجوی استاد و پژوهشگر

• Mechanobiology
• Ophthalmology
• Biomedical Engineering
• +۴ مورد دیگر

Darryl Overby is a Professor of Mechanobiology in the Department of Bioengineering at Imperial College London's Faculty of Engineering. His academic affiliations include the CRUK Convergence Science Centre, Cancer Technology Network, and multiple interdisciplinary networks focused on ocular biomechanics, vascular science, and regenerative medicine. He holds an Orcid identifier (0000-0001-9894-7515) and was previously affiliated with Tulane University and Harvard Medical School. Education: Ph.D. in Mechanical Engineering (2002) from MIT under Prof. Roger Kamm, followed by postdoctoral research at Harvard Medical School under Prof. Donald Ingber. His work focuses on cellular biomechanics, mechanotransduction, and the role of mechanical forces in intraocular pressure regulation and glaucoma pathophysiology. Research interests span mechanobiology of Schlemm’s canal endothelial cells, nitric oxide signaling in ocular tissues, and development of organ-on-chip models for studying aqueous humor outflow dynamics. His lab explores how mechanical signals drive transcellular pore formation and how these mechanisms fail in glaucomatous conditions. Key contributions include consensus guidelines for Brillouin microscopy measurements, ex vivo perfusion studies, and the role of TRPV4 channels in mechanosensing. His work integrates engineering techniques with clinical ophthalmology to advance therapies targeting glaucoma and ocular hypertension. Professional activities include leadership roles in the Ocular Biomechanics Network and Wound Healing and Regeneration Network. His research has led to patents for devices enhancing aqueous humor drainage and RNAi-based therapies.

Kristina Schoonjansمشاهده پروفایل

دانشیار

• Bile acid signaling
• Nutrient sensing
• Intermediary metabolism
• +۱۱ مورد دیگر

Kristina Schoonjans is an Associate Professor at EPFL’s School of Life Sciences, where she leads the Laboratory of Metabolic Signaling (UPSCHOONJANS). Her research focuses on the molecular mechanisms of bile acid signaling, nutrient sensing, and intermediary metabolism, particularly in the context of metabolic disorders such as obesity, fatty liver disease, and cancer. She investigates how the liver-gut-brain axis integrates metabolic signals through nuclear receptors and mitochondrial dynamics. Her research interests include: Bile acid signaling and its role as a hormonal regulator Nutrient and metabolite sensing in energy homeostasis Intermediary metabolism and metabolic disorders Role of nuclear receptors (e.g., TGR5, LRH-1) in liver, gut, and adipose tissue Mitochondrial dynamics and fission in metabolic regulation Organoid models for studying liver and intestinal metabolism Systems genetics using BXD mouse populations The most recent articles highlight a strong focus on bile acid signaling, particularly through TGR5 and LRH-1, in regulating metabolic health. Themes include the conversion of white fat to beige fat (beiging), hepatic tumorigenesis, mitochondrial fission, and the use of organoid and genetically engineered mouse models. There is a consistent emphasis on translational applications for obesity, fatty liver disease, and cancer. Scientific honors include: Windaus Prize from the Dr. Falk Foundation (2010, shared with Johan Auwerx) for the discovery of the signaling/endocrine function of bile acids Prof. Schoonjans actively supervises PhD students and has advised numerous doctoral candidates who have since completed their theses. Her lab is supported by multiple grants from Swiss and international funding agencies, including the Swiss National Science Foundation, EPFL, CONACYT, and the Foundation for Health and Education. She teaches in several doctoral programs at EPFL, including Life Sciences Engineering, and contributes to education through the SSV and EDBB/EDCB/EDMS-ENS programs. The Schoonjans Lab brings together scientists, doctoral assistants, and technicians working on projects related to metabolic signaling. The team uses advanced techniques such as genetically modified mouse models, organoid cultures, and multi-omics (metabolomics, proteomics, transcriptomics) to study the liver-gut and brain-liver axes. The lab has a strong track record of high-impact publications and collaborations with institutions worldwide.

Chris B. Schafferمشاهده پروفایل

استاد

• Biomedical Imaging and Instrumentation
• Bioengineering
• Neuroscience
• +۳ مورد دیگر

Chris B. Schaffer is a Professor in the Meinig School of Biomedical Engineering at Cornell University, specializing in developing advanced optical techniques to study neurovascular dynamics in neurological diseases. His lab focuses on Alzheimer’s disease mechanisms, leveraging multiphoton microscopy and in vivo imaging to explore capillary stalling, cerebral blood flow deficits, and their cognitive impacts. He holds a Ph.D. in Physics from Harvard University and postdoctoral training in neuroscience at UC San Diego. Research interests include biomedical imaging instrumentation, neurodegenerative disease modeling, and science education innovation. Awards include AAAS Fellowship (2021), AIMBE Fellowship (2019), and multiple teaching accolades. His work bridges engineering and medicine, with contributions to spinal cord injury studies, epilepsy, and vascular contributions to dementia (VCID). Notable discoveries include identifying neutrophil-induced capillary stalls as a key Alzheimer’s disease mechanism and demonstrating cerebral blood flow improvements can restore memory in mouse models. His lab also develops educational tools emphasizing science as a discovery process, used in K-12 and university settings.

Karthik Menonمشاهده پروفایل

استادیار

• Fluid Mechanics
• Bioengineering
• Computational Modeling
• +۵ مورد دیگر

Karthik Menon serves as an Assistant Professor with a joint appointment in the Woodruff School at Georgia Institute of Technology and the Coulter Department of Biomedical Engineering. His research integrates fluid mechanics, computational modeling, and data-driven methodologies to address critical challenges in healthcare, renewable energy, and bio-inspired engineering systems. His academic credentials include: Ph.D. in Mechanical Engineering, Johns Hopkins University (2021) M.S. in Mechanical Engineering, Johns Hopkins University (2019) B.E. in Mechanical Engineering, Birla Institute of Technology and Science, Pilani, India (2015) Menon's research program centers on three interconnected domains: cardiovascular flows for personalized treatment of heart disease, fluid-structure interactions in biological systems like heart valves and bio-mimetic robots, and vortex-dominated flows for renewable energy applications. His approach combines high-fidelity computational modeling with machine learning to uncover fundamental physics and develop clinical solutions, such as cardiovascular digital twins for non-invasive risk assessment. Current projects focus on patient-specific hemodynamics using CT imaging and uncertainty quantification to improve surgical planning. Analysis of his 15 most recent publications (2023-2025) reveals a dominant focus on advancing multi-fidelity computational frameworks for cardiovascular applications. Key trends include Bayesian uncertainty quantification, zero-dimensional solver development, and integration of clinical imaging data to create predictive digital twins. His work bridges fluid dynamics with clinical cardiology, targeting improved outcomes in coronary artery disease and Kawasaki-related complications through physics-informed machine learning. Menon's scholarly contributions have been recognized through competitive awards: WCCM-PANACM 2024 Travel Award, U.S. Association for Computational Mechanics (2024) Future Faculty Symposium Travel Award, Society of Engineering Science Conference (2023) Mark O. Robbins Prize in High-performance Computing, Johns Hopkins University (2021) Corrsin-Kovasznay Outstanding Paper Award, Johns Hopkins University (2020) Prosperetti Travel Award, Johns Hopkins University (2017) Mechanical Engineering Departmental Fellowship, Johns Hopkins University (2016) As principal investigator of the ComBiNE Fluid Dynamics Lab, Menon mentors graduate students in developing computational tools for fluid-structure interaction problems. His collaborative projects with cardiologists at Stanford and Emory hospitals translate engineering principles into clinical applications for cardiovascular disease management. Current grant activities focus on NSF and NIH-funded initiatives for uncertainty-aware cardiovascular modeling and bio-inspired flow energy harvesting. The ComBiNE Fluid Dynamics Lab operates as an interdisciplinary hub where engineers, clinicians, and data scientists collaborate on fluid mechanics challenges. Current lab initiatives include developing real-time hemodynamic simulators for surgical planning, creating reduced-order models for cardiac device optimization, and investigating vortex dynamics in fish schooling for underwater vehicle design. The lab maintains strong partnerships with Children's Healthcare of Atlanta and the Parker H. Petit Institute for Bioengineering and Bioscience.

Sudin Bhattacharyaمشاهده پروفایل

دانشیار

• Systems Toxicology
• Computational Biology
• Gene Expression Analysis
• +۳ مورد دیگر

Sudin Bhattacharya is an Associate Professor at the BioMolecular Science Gateway, Michigan State University, with affiliations in the Genetics & Genome Sciences Program and Cell & Molecular Biology Program. His research bridges computational biology and toxicology to understand complex biological systems. Email: sbhattac@msu.edu Research Interests Dr. Bhattacharya specializes in systems toxicology, focusing on computational modeling of gene regulatory networks, single-cell transcriptomics, and molecular dynamics in response to environmental toxicants. His work examines how chemical exposures disrupt cellular pathways and contribute to disease mechanisms. Article Trends His recent publications emphasize: Single-cell and single-nucleus RNA sequencing for toxicological profiling Computational models of circadian rhythms and intercellular communication Dose-dependent responses to environmental chemicals like TCDD and heavy metals Mechanistic studies of adipose tissue remodeling and hypertension Applications of machine learning in chemical risk assessment Integrative approaches to liver metabolism and disease modeling Scientific Contributions Dr. Bhattacharya has pioneered multiscale modeling of biological systems, particularly in hepatic and vascular contexts. His work on the aryl hydrocarbon receptor and PPARα signaling networks has advanced predictive toxicology frameworks.

Prashant Maliمشاهده پروفایل

استاد

• Genome Engineering
• RNA Editing
• Stem Cell Research
• +۴ مورد دیگر

Prashant Mali is a Professor in the Department of Bioengineering at the University of California, San Diego . His research bridges genome engineering, RNA biology, and biomedical applications, with a focus on CRISPR-Cas systems and ADAR-mediated RNA editing. Education : Ph.D. in Bioengineering Key Affiliations : UC San Diego, Altman Clinical and Translational Research Institute Dr. Mali's work centers on CRISPR-Cas9 technology , RNA editing , and human pluripotent stem cells . His lab develops tools for programmable gene regulation, synthetic lethal screens, and metabolic pathway analysis in disease contexts. Recent publications highlight innovations in circular RNA engineering , ADAR activity mapping , and metabolic reprogramming in cancer . His team employs multi-omics approaches and in vivo models to translate genome editing into clinical applications. Students and Collaborators Current Lab Members : Sami Nourreddine (Postdoc), Amir Dailamy (Graduate), Andrew Portell (Graduate), Michael Tong (Graduate) Alumni : Kyle Ford (PhD 2022), Nathan Palmer (PhD 2022), Udit Parekh (PhD 2021) Research Themes CRISPR Screens : Synthetic lethal interactions, oncogenic pathways, metabolic vulnerabilities RNA Editing : ADAR engineering, circular guide RNAs, clinical translation Tissue Engineering : Vascularized organoids, cardiac maturation, ex vivo models

Su Ryon Shinمشاهده پروفایل

استادیار

• Bioengineering
• Tissue Engineering
• 3D Bioprinting
• +۷ مورد دیگر

Dr. Su Ryon Shin is an Assistant Professor in the Division of Engineering in Medicine at Harvard Medical School and Brigham and Women's Hospital (BWH) in Cambridge, MA. She leads an active research laboratory focused on bioengineering, tissue engineering, and regenerative medicine, with particular expertise in 3D bioprinting, biomaterials, and organ-on-a-chip technology. Her research interests span biohybrid robotics, decellularized extracellular matrix, stem cell-based tissue engineering, and volumetric muscle regeneration . Dr. Shin's work integrates advanced biomaterials with cellular systems to create innovative solutions for tissue regeneration and disease modeling. She has pioneered approaches using human stem cell-derived materials for volumetric tissue regeneration and developed biohybrid neuromuscular robots powered by living cardiac muscle cells. Her publication record demonstrates consistent productivity with over 180 publications, including numerous first/senior author papers in high-impact journals like Science Robotics, Advanced Materials, and Nature Reviews Bioengineering . Her work shows a clear progression from fundamental biomaterials development to increasingly complex tissue engineering applications and translational research. Dr. Shin has received significant recognition including being named a 2025 BWH Health & Technology Innovation Awardee , Highly Cited Researcher 2024 by Web of Science, and multiple Stepping Strong Innovator Awards (2015, 2018, 2020). Her research has been featured in Nature Reviews Bioengineering for breakthrough work on biohybrid robots. She actively mentors students and postdocs, with former lab members accepted to prestigious programs like MIT's PhD program in Chemical Engineering. Her collaborative approach is evident through numerous interdisciplinary projects with researchers across Harvard Medical School, BWH, and international institutions.

Michael Harrisonمشاهده پروفایل

استادیار

• Vascular Biology
• Regenerative Medicine
• Developmental Biology
• +۱۱ مورد دیگر

Michael Harrison is an Assistant Professor in the Department of Cell and Developmental Biology at Weill Cornell Medicine, where he leads the Regeneration and Development Lab within the Graduate School of Medical Sciences. His research focuses on vascular development and regeneration using zebrafish as a model organism, with emphasis on coronary and cerebral vasculature. Education: B.Sc. in Genetics, University of Edinburgh (2005) Ph.D. in Developmental Genetics, University of Sheffield (mentor: Vincent Cunliffe) Postdoctoral Fellowship, Saban Research Institute, Children’s Hospital Los Angeles (CIRM Fellow) Harrison's research centers on understanding how blood and lymphatic vessels form and regenerate, particularly in the heart and brain. His lab investigates coronary vessel development, the role of lymphatic systems in inflammation and regeneration, and revascularization after injury. By leveraging zebrafish genetics and advanced imaging, his work aims to uncover pathways that could be harnessed for regenerative therapies in humans. His recent publications reveal key signaling mechanisms such as Cxcr4-Cxcl12 in coronary development and the two-step formation of cardiac lymphatics. The 15 most recent articles demonstrate a strong, consistent research trajectory in vascular biology and regeneration, with increasing use of advanced techniques like single-nuclei multiomics, fluidic imaging devices, and CRISPR-based genome editing. His work spans developmental mechanisms, functional imaging, and translational applications in cardiac repair. Scientific Awards: No awards explicitly mentioned in the provided text. Harrison actively mentors a team of postdoctoral fellows, research assistants, and students, several of whom have progressed to medical school or research careers. His lab collaborates extensively, particularly with Ching-Ling Lien's group. He has secured research space and funding to support ongoing projects in cardiac and cerebral vasculature. The lab is actively recruiting rotation students from BCMB, PBSB, IMP, and Tri-Institutional programs, as well as postdoctoral researchers and research assistants, indicating an expanding research team and active grant support. Labs and Teams: Regeneration and Development Lab, Weill Cornell Medicine Collaborations with Ching-Ling Lien Lab Member of Tri-Institutional PhD Programs Active participation in BCMB, PBSB, and IMP training programs

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۵ مورد دیگر

João F. Mano is a Full Professor at the Department of Chemistry, University of Aveiro, and Director of the Doctoral Program on Biotechnology. He leads the COMPASS Research Group and serves as Vice-Director at CICECO - Aveiro Institute of Materials. His academic appointments include Invited Professor at University of Lorraine (France), Visiting Professor at KAIST (South Korea), and Adjunct Professor at Ajou University (South Korea). Education: PhD in Chemistry (1996, Technical University of Lisbon); D.Sc. in Tissue Engineering, Regenerative Medicine and Stem Cells (2012, University of Minho) Research Interests focus on Biomaterials for Regenerative Medicine , integrating Nanotechnology , Microtechnology , and Biofabrication . His group develops Bioinspired Materials using polymer chemistry, Decellularized Extracellular Matrix , and 3D Bioprinting to engineer Cell Microenvironments for therapeutic applications. Recent Publications highlight advancements in Human-Derived Hydrogels , Photopolymerizable Scaffolds , Magneto-Responsive Biomaterials , and Programmable Bioinks . Trends show emphasis on Organ-on-a-Chip integration, Smart Living Materials , and Green Bioprinting methodologies. Scientific Awards include: European Research Council Advanced Grants (2015, 2020) Fellow at IUPAC, European Academy of Sciences, and American Institute of Medical and Biological Engineering ERC Proof of Concept Grants Doctor Honoris Causa from University of Lorraine and Utrecht UNESCO Chair on Biomaterials George Winter Award (European Society for Biomaterials) Supervisions & Collaborations encompass 74+ MSc, 26+ PhD students, and 40+ postdocs. He co-founded METATISSUE and CELLULARIS Biomodels , and serves as Editor-in-Chief of Materials Today Bio .

Adam Feinbergمشاهده پروفایل

استاد

• Biomedical Engineering
• Tissue Engineering
• 3D Bioprinting
• +۶ مورد دیگر

Adam Feinberg is a Professor in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University (CMU). He leads the Regenerative Biomaterials & Therapeutics Group, focusing on cell-material interactions, 3D bioprinting, and bioengineered tissues. His work integrates nanofabrication, molecular biology, and 3D imaging to address challenges in muscle repair, corneal regeneration, and cancer. Key innovations include the FRESH bioprinting platform, enabling soft ECM gel-based constructs, and ECM shrink-wrapping techniques for cell encapsulation. Feinberg holds a Ph.D. and MS in Biomedical Engineering from the University of Florida (2004, 2002) and a BS in Materials Science and Engineering from Cornell University (1999). He has secured major grants, including ARPA-H funding for diabetes treatments and Canada’s New Frontiers Fund for heart disease therapies. His research has led to over 45 peer-reviewed articles and 20 patents. His scientific awards include the NIH Director’s New Innovator Award and NSF CAREER Award. Media highlights include breakthroughs in vascularized tissue models and biodegradable actuators. Feinberg collaborates widely, advancing clinical translation of bioprinted tissues and sustainable bio-bots.

James McGrathمشاهده پروفایل

استاد

• Nanomembranes
• Microphysiological systems
• Biosensors
• +۷ مورد دیگر

James McGrath is a Professor of Biomedical Engineering at the University of Rochester, holding the William R. Kenan, Jr. Professorship. He leads the Nanomembrane Research Group, pioneering ultrathin silicon nanomembrane technologies for biomedical applications. His work integrates material science, microfluidics, and tissue engineering to address challenges in diagnostics, regenerative medicine, and environmental health. McGrath's interdisciplinary team collaborates across academia and industry, including the Rochester-based SiMPore Inc. (co-founded by him). Education: B.S. Mechanical Engineering, Arizona State University (1991) M.S. Mechanical Engineering, MIT (1994) Ph.D. Biological Engineering, Harvard/MIT (1998) Research Interests: McGrath focuses on nanomembrane technologies for: Microphysiological systems (organ-on-a-chip) Biosensors and diagnostic tools Hemodialysis and toxin removal Microplastics detection in water and biological systems Inflammatory fibrosis modeling (e.g., blood-brain barrier dynamics) Extracellular vesicle biomarker platforms Awards & Recognition: Edmund A. Hajim Outstanding Faculty Award (2019) AIMBE Fellow (2015) William R. Kenan, Jr. Professorship (2023) Advising & Industry: McGrath has advised students and entrepreneurs through his lab and SiMPore Inc., focusing on translating nanomembrane innovations into clinical and commercial applications. His work bridges basic science and applied engineering, with a focus on scalable manufacturing and global health impact. Labs & Collaborations: The Nanomembrane Research Group collaborates with UR, RIT, and international partners to advance nanomembrane-based solutions for healthcare and environmental challenges. Key platforms include the MicroSiM barrier tissue system and silicon nanomembrane analysis pipelines.

• Biomedical imaging
• Diffusion weighted imaging
• Dynamic imaging
• +۷ مورد دیگر

Brad Sutton is a Professor of Bioengineering at the University of Illinois Urbana-Champaign and Technical Director of the Biomedical Imaging Center at Beckman Institute. He holds affiliate roles in the Neuroscience Program, Department of Electrical and Computer Engineering, and is a Health Innovation Professor at the Carle Illinois College of Medicine. His roles also include fellowship positions with the National Center for Supercomputing Applications and the CZ Biohub Chicago. Education: Ph.D. in Biomedical Engineering from the University of Michigan (2003). Research Interests: Focus on advanced MRI techniques for structural and functional brain imaging, including diffusion-weighted imaging, dynamic imaging, and neuromuscular coupling studies. His work emphasizes multi-scale bioimaging to understand brain function across interventions, aging, and disease. Publications: Over 180 peer-reviewed articles in 2025-2024 highlight innovations in MRI technology and applications in neuroscience, including breakthroughs in laminar fMRI specificity, myelin development modeling, and Alzheimer’s biomarker studies. Recent work extends to clinical applications like aortic imaging automation and mixed reality training tools. Awards: AIMBE and ISMRM Fellowships (2017/2024), Abel Bliss Scholar (2014-), and over 9 patents in imaging techniques. Labs & Teams: Leads the Magnetic Resonance Functional Imaging Lab. Collaborates with interdisciplinary teams across engineering, medicine, and computational science to advance imaging technologies and their clinical translation.

Tatiana Seguraمشاهده پروفایل

استاد

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۵ مورد دیگر

Tatiana Segura is a Professor of Biomedical Engineering, Neurology, and Dermatology at Duke University's Pratt School of Engineering, where she also serves as Co-director of the Center for Biotechnology and Tissue Engineering and MPI of the T32 Biotechnology Training grant. Her research focuses on designing biomaterials to promote endogenous repair through geometry design and delivery of genes, proteins, and drugs. She has made significant contributions to the development of microporous annealed particle (MAP) hydrogels and other biomaterial systems for tissue regeneration. B.S. in Bioengineering from University of California, Berkeley (1999) Ph.D. in Chemical Engineering from Northwestern University (2004) Professor Segura's research centers on biomaterials engineering for tissue repair and regeneration. Her lab designs innovative biomaterial interventions that promote brain plasticity after stroke, enable scarless healing in skin wounds, induce tolerance of transplanted skin, and promote constructive immune responses after biomaterial implantation. She pioneered the development of microporous annealed particle (MAP) hydrogels that have become widely adopted in regenerative medicine research. Her work uniquely bridges immunology, materials science, and clinical applications to create therapeutic biomaterials that harness the body's own healing capabilities. Her recent publications demonstrate a strong focus on spatial control of biomaterial properties, with emphasis on void space analysis, immune cell recruitment, and vascularization. The research shows a progression from fundamental biomaterial characterization to increasingly sophisticated therapeutic applications, particularly in stroke recovery and wound healing. Her work integrates proteomics, lipidomics, and advanced imaging to understand the molecular mechanisms underlying biomaterial-mediated tissue regeneration. Senior Member of the National Academy of Inventors (2023) Acta Biomaterialia Silver Medal (2021) Clemson Award for Contributions to Literature (2024) 15 d/e Plenary Award from AICHE Food, Pharmaceutical, and Bioengineering Division (2018) Fellow of the American Institute for Medical and Biological Engineers (2016) Professor Segura actively mentors the next generation of scientists, currently supervising 12 graduate students, 4 postdoctoral scholars, 2 master's students, 16 undergraduates, and other trainees. Her laboratory has been continuously funded since 2008 with multiple NIH grants, including her current role as MPI of the T32 Biotechnology Training grant. She has received substantial support from the NSF (including a CAREER award), American Heart Association, and American Society of Gene and Cell Therapy. Her Segura Lab operates as a multidisciplinary team comprising engineers, biologists, and clinicians working together to translate biomaterial discoveries into clinical applications. The lab's 'MAP' technology platform has enabled numerous collaborations across Duke and other institutions, focusing on brain repair after stroke, scarless skin healing, and immune-modulating biomaterials. The lab maintains strong industry partnerships to accelerate the translation of their biomaterial technologies into clinical use.

Andrew de Melloمشاهده پروفایل

استاد

• Microfluidics
• Nanotechnology
• Bioanalytical Chemistry
• +۵ مورد دیگر

Andrew de Mello serves as Full Professor and Deputy Head at ETH Zurich's Department of Chemistry and Applied Biosciences, where he also leads the Institute of Chemical and Bioengineering. His research group operates at the intersection of microfluidics and nanoscale science, maintaining a highly international team with members from over 15 countries. The deMello Group specializes in microfluidic device development for high-throughput biological analysis, ultrasensitive optical detection , nanofluidic chemical synthesis systems , and imaging flow cytometry . Their work spans analytical chemistry, biomedical engineering, and diagnostic applications, with recent projects focusing on paper-based electrofluidic devices, synthetic gene circuits for tuberculosis detection, and droplet-based microfluidics for mRNA screening. Professor de Mello's scholarly contributions include over 350 peer-reviewed publications and two co-authored books. His editorial leadership includes serving as Associate Editor for ACS Sensors and on editorial boards for Advanced Materials Technologies, Chem, and Chemistry World. Advances in Measurement Science Lectureship (ACS, 2020) Qinghe Lectureship (Chinese Academy of Sciences, 2018) Corday-Morgan Medal (RSC, 2009) Clifford Paterson Medal (Royal Society, 2009) SAC Silver Medal (RSC, 2002) His research group actively mentors doctoral students across diverse projects including microrobot fabrication, tumor spheroid vascularization, and spatial tissue mapping. Current grants support development of diagnostic platforms for kidney function monitoring and drug-resistant tuberculosis detection, with collaborations spanning ETH Zurich, Universitätsspital Zürich, and international institutions.

Andrés J. Garcíaمشاهده پروفایل

استاد

• Bioengineering
• Regenerative Medicine
• Biomaterials
• +۷ مورد دیگر

Andrés J. García is the Executive Director of the Parker H. Petit Institute for Bioengineering & Bioscience and a Regents’ Professor in the George Woodruff School of Mechanical Engineering at Georgia Institute of Technology. His research focuses on engineered biomaterials for regenerative medicine, including tissue repair, inflammation modulation, and cell adhesion mechanisms. He co-founded three startups (CellectCell, CorAmi Therapeutics, iTolerance) and holds multiple patents in biomaterials and drug delivery systems. Education: Ph.D., University of Pennsylvania, 1996 M.S.E., University of Pennsylvania, 1992 B.S., Cornell University, 1991 Research Interests: García’s work integrates engineering, materials science, and cell biology to develop biomaterials that direct cellular responses. Key areas include: Biomaterial platforms for bone repair and vascularization Immunomodulatory hydrogels for islet transplantation Antibacterial hydrogels for implant infection control Organoid generation using synthetic hydrogels Mechanisms of cell adhesion and mechanotransduction Publications: Over 30+ peer-reviewed articles in Nature Communications , Science Advances , Biomaterials , and others, highlighting innovations in hydrogel design, stem cell therapies, and biomaterial-driven tissue repair. Awards: Member of both the National Academy of Engineering and National Academy of Medicine (2021), Clemson Award for Basic Research (2012), and Fellowships with the American Society of Mechanical Engineers and AAAS. Labs/Teams: Leads the García Laboratory, collaborating across disciplines to translate biomaterials research into clinical applications. Active in startup partnerships and federal grants (e.g., NSF, NIH).